Innovation in Oncology: The Synergy of New and Old Drugs

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 23 Sept, 13:15 UTC

Years of joint industry-academic engineering suggest that highly engineered single agents will not be the most effective treatments for solid tumors; the solution will be combining the right drugs and administering them in the right way. The post Innovation in Oncology: The Synergy of New and Old…

science

Sources

• T2Innovation in Oncology: The Synergy of New and Old DrugsFierce Biotech / Fierce Healthcare / MedCity / GEN23 Sept, 13:15